Laurel Wealth Advisors, Inc. - GLAXOSMITHKLINE PLC ownership

GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 887 filers reported holding GLAXOSMITHKLINE PLC in Q4 2019. The put-call ratio across all filers is 0.83 and the average weighting 0.3%.

Quarter-by-quarter ownership
Laurel Wealth Advisors, Inc. ownership history of GLAXOSMITHKLINE PLC
ValueSharesWeighting
Q1 2022$212,000
-9.0%
4,856
-7.9%
0.02%0.0%
Q4 2021$233,000
+0.4%
5,273
-13.0%
0.02%
-58.1%
Q3 2021$232,000
-10.8%
6,064
-7.2%
0.04%
+26.5%
Q2 2021$260,000
+14.0%
6,532
+2.2%
0.03%
-2.9%
Q1 2021$228,000
-3.0%
6,394
+0.2%
0.04%0.0%
Q4 2020$235,000
+2.6%
6,384
+5.0%
0.04%
-7.9%
Q3 2020$229,000
-7.7%
6,0800.0%0.04%
-15.6%
Q2 2020$248,000
+8.8%
6,080
+0.8%
0.04%
-13.5%
Q1 2020$228,000
-21.4%
6,029
-2.3%
0.05%
+6.1%
Q4 2019$290,000
-42.2%
6,171
-47.6%
0.05%
-43.0%
Q3 2019$502,000
+43.0%
11,766
+34.1%
0.09%
+11.7%
Q2 2019$351,000
-6.1%
8,775
-1.9%
0.08%
-16.3%
Q1 2019$374,000
-55.9%
8,942
-59.8%
0.09%
-63.2%
Q4 2018$849,000
-11.6%
22,242
-6.9%
0.25%
+5.9%
Q3 2018$960,000
+0.9%
23,898
+1.2%
0.24%
-6.7%
Q2 2018$951,000
+1.5%
23,614
-1.5%
0.25%
-12.8%
Q1 2018$937,000
-7.5%
23,984
-16.0%
0.29%
-0.3%
Q4 2017$1,013,000
-13.8%
28,567
-1.3%
0.29%
-26.1%
Q3 2017$1,175,000
-1.8%
28,951
+4.3%
0.39%
-7.3%
Q2 2017$1,196,000
+4.9%
27,757
+2.6%
0.42%
-3.4%
Q1 2017$1,140,000
+2.8%
27,060
-6.0%
0.44%
-10.4%
Q4 2016$1,109,000
+3.5%
28,801
+15.9%
0.49%
-3.2%
Q3 2016$1,072,000
-4.5%
24,860
-4.1%
0.51%
-5.9%
Q2 2016$1,123,000
+3.0%
25,921
-3.6%
0.54%
-1.5%
Q1 2016$1,090,000
-7.5%
26,892
-7.9%
0.55%
-10.2%
Q4 2015$1,178,00029,1920.61%
Other shareholders
GLAXOSMITHKLINE PLC shareholders Q4 2019
NameSharesValueWeighting ↓
Sio Capital Management, LLC 325,823$11,557,0006.52%
KAHN BROTHERS GROUP INC 1,139,163$40,406,111,0006.35%
Chubb Ltd 400,000$14,188,0006.18%
Healthcare Value Capital, LLC 50,000$1,774,0005.40%
CLARK ESTATES INC/NY 650,000$23,056,0003.81%
PVG ASSET MANAGEMENT CORP 220,450$7,819,361,0003.57%
Martin Capital Partners, LLC 88,195$3,128,0003.25%
Camber Capital Management LP 1,500,000$53,205,0002.60%
EQUITY INVESTMENT CORP 2,090,120$74,137,0002.47%
Keystone Financial Planning, Inc. 129,102$4,579,0002.44%
View complete list of GLAXOSMITHKLINE PLC shareholders